Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dosis is a private healthcare software company focused on AI-enabled precision dosing and clinical decision support for chronic disease management. Its lead commercial product, Strategic Anemia Advisor, helps dialysis providers personalize erythropoiesis-stimulating agent dosing for patients with chronic anemia, particularly in chronic kidney disease settings. The company also launched Strategic Iron Advisor to support individualized intravenous iron dosing as part of anemia management. Dosis positions its technology as a way to improve patient outcomes, increase safety, and reduce unnecessary drug utilization and cost for providers. The business operates at the intersection of precision medicine, nephrology, and healthcare AI rather than as a therapeutic drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dosis.